Müller V, Lehner M, Klein P, Hohenberger W, Ott R
Department of Surgery, University of Erlangen-Nuremberg, Krankenhausstrasse 12, 91054 Erlangen, Germany.
Langenbecks Arch Surg. 2003 Jul;388(3):167-73. doi: 10.1007/s00423-003-0384-4. Epub 2003 Jun 17.
The literature provides no data on the incidence and operative management of incisional hernias developing after orthotopic liver transplantation. The use of high-dose immunosuppressive agents results in an appreciable delay in wound healing. There is thus a need for a procedure for the reconstruction of the abdominal wall for patients on immunosuppression. The aim of this retrospective study was to establish the incidence of incisional hernias and an analysis of the results after implantation of a polypropylene mesh in inlay-onlay technique after liver transplantation is given.
The basis for the present retrospective investigations was a total of 207 liver transplantations carried out in 192 patients (15 re-transplantations). After performing tensiometry, a polypropylene mesh (Marlex) was implanted to close the hernias using the inlay/onlay technique or a direct closure of the fascia was done. All treated hernias were followed up for a median of 18 months.
Among 184 patients, 17 developed incisional hernias after primary direct closure of the abdominal wall, giving an incidence of 9%. In an additional 8 patients an incisional hernia was seen where an absorbable mesh was used to close the abdominal wall after liver transplantation. In addition, there were 25 incisional hernias after 207 liver transplantations (12%). One of 15 (7%) of the surgically repaired hernias with implantation of a polypropylene mesh (Marlex) developed a recurrence. All the 3 patients after direct apposition of the fascia without using a polypropylene mesh suffered a recurrence (3 of 3; 100%). Significant risk factors for developing an incisional hernia were the amount of ascites and the stay in the ICU after transplantation. Neither severe deep nor superficial wound infection nor bowel fistulas were observed after implantation of a inlay/onlay mesh.
In patients after liver transplantation, the implantation of a polypropylene mesh proved to be an efficient and safe method of treating incisional hernias. Implantation of a mesh was not associated with an increased infection rate, despite the use of immunosuppression. In view of the high recurrence rate associated with primary closure, mesh implantation should be given preference.
文献中没有关于原位肝移植后发生切口疝的发生率及手术处理的数据。大剂量免疫抑制剂的使用导致伤口愈合明显延迟。因此,需要一种针对接受免疫抑制治疗患者的腹壁重建手术方法。本回顾性研究的目的是确定切口疝的发生率,并分析肝移植后采用聚丙烯网片嵌体-覆盖技术植入后的结果。
本回顾性研究的基础是对192例患者(其中15例再次移植)进行的207例肝移植手术。在进行张力测定后,使用嵌体/覆盖技术植入聚丙烯网片(Marlex)来闭合疝,或直接缝合筋膜。所有接受治疗的疝均随访了中位时间18个月。
在184例患者中,17例在腹壁初次直接缝合后发生切口疝,发生率为9%。另外8例患者在肝移植后使用可吸收网片闭合腹壁时出现切口疝。此外,207例肝移植后有25例切口疝(12%)。在15例采用聚丙烯网片(Marlex)植入手术修复的疝中,有1例(7%)复发。3例未使用聚丙烯网片直接缝合筋膜的患者均复发(3/3;100%)。发生切口疝的显著危险因素是腹水量和移植后在重症监护病房的停留时间。植入嵌体/覆盖网片后未观察到严重的深部或浅表伤口感染及肠瘘。
在肝移植患者中,植入聚丙烯网片被证明是治疗切口疝的一种有效且安全的方法。尽管使用了免疫抑制剂,但植入网片并未增加感染率。鉴于一期缝合相关的高复发率,应优先选择植入网片。